Traws Pharma
TRAW
TRAW
12 hedge funds and large institutions have $7.63M invested in Traws Pharma in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
25% less funds holding
Funds holding: 16 → 12 (-4)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
12
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$64K | |
| 2 | +$29.4K | |
| 3 | +$7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6K |
Top Sellers
| 1 | -$893K | |
| 2 | -$101K | |
| 3 | -$62K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$32K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$30K |